CMS releases ICD-10 codes for new COVID-19 therapies
The Centers for Medicare & Medicaid Services today added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.
These include remdesivir and convalescent plasma, as well as any future COVID-19 therapeutic that does not have a unique name.
CMS also released a new ICD-10 Medicare Severity-Diagnosis Related Group Grouper software package (Version 37.2) to accommodate the new codes, effective for discharges on or after Aug. 1.
The new codes will not affect the MS-DRG assignment.
Related News Articles
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…